Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawFetal Tissue, Stem Cells & Bioethics

Written Testimony of Tara Sander Lee, Ph.D., on Prohibiting Prenatal Discrimination

In October  2021, Dr. Tara Sander Lee, Senior Fellow and Director of Life Sciences at the Charlotte Lozier Institute, testified in front of the Wisconsin Legislature, in both the House and Senate, on Assembly Bill 595 and Senate Bill 593 concerning prohibiting abortion solely based on the “race, color, national origin, ancestry, or sex of the unborn child or solely because the unborn child has been diagnosed with or has a potential diagnosis of Down syndrome or another congenital disability.” Dr. Sander Lee’s testimony focused on the science of prenatal screening and diagnosis of Down syndrome. In her testimony, she notes that many  forms of screening for Down syndrome, such as non-invasive prenatal screening (NIPS) that uses fetal DNA found in the mother’s blood, have low positive predictor values, and points to the need to use medical testing at the service of the patient: “There are significant medical advancements that use prenatal screens and tests to heal and not harm the developing baby.” She continued: “We need to consider these young individuals as equally valued human lives. Eliminating young lives is not the answer to eliminating disease and disability once a risk of the disorder is identified. Destroying the patient is not curative medicine. Such acts become a modern-day form of eugenics.”

 

To view Dr. Sander Lee’s testimony in PDF format, please see, Written Testimony of Tara Sander Lee, Ph.D., on Prohibiting Prenatal Discrimination

 

To learn more about Down syndrome and prenatal testing, please see, https://lozierinstitute.org/dive-deeper/down-syndrome/ 

 

(Dr. Tara Sander Lee testifying on AB 595 on Oct. 7, 2021)

 

Latest Posts

December 10, 2024 A Defense of New Jersey Pregnancy Centers: Responding to Planned Parenthood Misinformation November 27, 2024 Abortion Reporting: Massachusetts (2023) November 27, 2024 Abortion Reporting: Maine (2023)

You Might Also Be Interested In

A Defense of New Jersey Pregnancy Centers: Responding to Planned Parenthood Misinformation

December 10, 2024
Please login to bookmarkClose

The Treatment of Human Embryos Created through IVF: The U.S. and 15 Selected Countries’ Regulations

November 22, 2024
Please login to bookmarkClose

IVF Industry Regulation in the United States: Changes Are Needed to Protect Embryonic Children and their Families

November 13, 2024
Please login to bookmarkClose

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image